
Technology distribution company ScanSource (NASDAQ:SCSC) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 17.3% year on year to $953.1 million. Its non-GAAP profit of $1.46 per share was 28% above analysts’ consensus estimates.
Is now the time to buy SCSC? Find out in our full research report (it’s free for active Edge members).
ScanSource’s second quarter was marked by strong top-line growth and a positive market reaction, driven largely by momentum in both its Specialty Technology Solutions and Intelisys and Advisory segments. Management pointed to organic net sales growth and solid free cash flow generation, while acknowledging some unexpected period expenses that weighed on margins. CEO Michael L. Baur attributed the quarter’s performance to increased partner engagement and the impact of recent acquisitions, such as DataZoom, noting, “Our investment strategy is driving growth and momentum in new orders.”
Looking forward, ScanSource’s guidance is underpinned by expectations for renewed large deal activity and the rollout of its new converged communications sales team. Management emphasized the potential of unified hardware and cloud offerings to capture greater partner wallet share and highlighted investments in the Intelisys segment to accelerate order growth. CFO Stephen T. Jones stated, “We believe new order growth that we referenced is growing faster than our billings, and that’s indicative of what we’ll see next year.” Leadership remains focused on executing its three-year strategic plan and expanding recurring revenue streams.
Management attributed Q2 performance to steady organic growth across both business segments, operational integration of recent acquisitions, and strategic alignment of sales capabilities to address evolving partner and customer needs.
ScanSource’s outlook is shaped by the anticipated resumption of large deals, continued investment in sales and partner alignment, and industry-wide supply chain uncertainties.
Looking ahead, the StockStory team will be watching (1) the pace at which large deals resume and their impact on revenue timing, (2) evidence that the new converged communications sales team is effectively driving partner engagement and cloud adoption, and (3) progress in converting Intelisys new order momentum into billings and recurring revenue. Continued monitoring of supply chain dynamics and margin improvement efforts will also be crucial for tracking execution of ScanSource’s strategy.
ScanSource currently trades at $56.18, up from $51.42 just before the earnings. Is the company at an inflection point that warrants a buy or sell? Find out in our full research report (it’s free).
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.